<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02002806</url>
  </required_header>
  <id_info>
    <org_study_id>1011003552</org_study_id>
    <nct_id>NCT02002806</nct_id>
  </id_info>
  <brief_title>Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control</brief_title>
  <official_title>A Randomized Controlled Trial of Intraoperative Chemical Splanchnicectomy for Patients With Resected Pancreatobiliary Malignancies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized study of surgery plus chemical nerve block versus surgery plus placebo
      for pain control in subjects with pancreatic cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thi is a study of pain control in subjects undergoing surgery for pancreatic or bile duct
      cancer.

      Subjects undergoing surgery will be randomized to surgery plus celiac plexus neurolysis with
      ethanol injection versus surgery plus placebo injection. Subjects will be followed every
      three months for survivorship or death to assess pain, quality of life measures, and narcotic
      pain control usage. The primary endpoint of pain control will be determined at one year post
      surgery. Subjects are not required to undergo any additional diagnostic testing procedures
      that are not part of their routine follow-up care.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Control</measure>
    <time_frame>12 Months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease-specific, recurrence-free survival</measure>
    <time_frame>2 Years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Pancreas Cancer</condition>
  <condition>Biliary Tract Cancer</condition>
  <arm_group>
    <arm_group_label>Alcohol Injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Celiac plexus neurolysis by alcohol injection One time administration during surgery 20 ml of alcohol injection on each side of aorta at level of celiac axis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Injection</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Celiac plexus injection - placebo injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Alcohol Injection</intervention_name>
    <description>Celiac plexus neurolysis by alcohol injection</description>
    <arm_group_label>Alcohol Injection</arm_group_label>
    <other_name>Ethanol Injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Injection</intervention_name>
    <arm_group_label>Placebo Injection</arm_group_label>
    <other_name>Normal saline injection</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        This study will be offered to all patients scheduled to undergo open or laparoscopic
        operative resection of a presumed pancreatic (any location; i.e., head, body, or tail) or
        distal biliary tract cancer.

          -  Physiologic suitability for major abdominal surgery

          -  Aged 18 years and older

          -  Written informed consent

          -  Ability to understand and comply with study guidelines.

        Exclusion Criteria:

          -  Pregnancy

          -  Previous, preoperative celiac nerve block

          -  Neoadjuvant chemotherapy or radiation therapy

          -  Incomplete tumor resection (R2 resection, grossly positive resection margin)

          -  Presumed ampullary or duodenal cancer based on preoperative work-up or intraoperative
             findings

          -  Benign tumors, neuroendocrine tumors, soft tissue tumors based on preoperative work-up
             or intraoperative findings

          -  Known metastatic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael G House, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University, Department of Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2013</study_first_submitted>
  <study_first_submitted_qc>December 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2013</study_first_posted>
  <last_update_submitted>April 23, 2018</last_update_submitted>
  <last_update_submitted_qc>April 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>Michael G. House</investigator_full_name>
    <investigator_title>Associate Professor of Surgery</investigator_title>
  </responsible_party>
  <keyword>Pancreatic cancer</keyword>
  <keyword>Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Biliary Tract Neoplasms</mesh_term>
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

